Literature DB >> 11907208

Selection of RNA aptamers that are specific and high-affinity ligands of the hepatitis C virus RNA-dependent RNA polymerase.

Antonino Biroccio1, Jörg Hamm, Ilario Incitti, Raffaele De Francesco, Licia Tomei.   

Abstract

In order to find small RNA molecules that are specific and high-affinity ligands of nonstructural 5B (NS5B) polymerase, we screened by SELEX (systematic evolution of ligands by exponential amplification) a structurally constrained RNA library with an NS5BDeltaC55 enzyme carrying a C-terminal biotinylation sequence. Among the selected clones, two aptamers appeared to be high-affinity ligands of NS5B, with apparent dissociation constants in the low nanomolar range. They share a sequence that can assume a stem-loop structure. By mutation analysis, this structure has been shown to correspond to the RNA motif responsible for the tight interaction with NS5B. The aptamers appeared to be highly specific for the hepatitis C virus (HCV) polymerase since interaction with the GB virus B (GBV-B) NS5B protein cannot be observed. This is consistent with the observation that the activity of the HCV NS5B polymerase is efficiently inhibited by the selected aptamers, while neither GBV-B nor poliovirus 3D polymerases are affected. The mechanism of inhibition of the NS5B activity turned out to be noncompetitive with respect to template RNA, suggesting that aptamers and template RNA do not bind to the same site. As a matter of fact, mutations introduced in a basic exposed surface of the thumb domain severely impaired both the binding of and activity inhibition by the RNA aptamers.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11907208      PMCID: PMC136087          DOI: 10.1128/jvi.76.8.3688-3696.2002

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  44 in total

Review 1.  RNA bulges as architectural and recognition motifs.

Authors:  T Hermann; D J Patel
Journal:  Structure       Date:  2000-03-15       Impact factor: 5.006

2.  Only a small fraction of purified hepatitis C RNA-dependent RNA polymerase is catalytically competent: implications for viral replication and in vitro assays.

Authors:  S S Carroll; V Sardana; Z Yang; A R Jacobs; C Mizenko; D Hall; L Hill; J Zugay-Murphy; L C Kuo
Journal:  Biochemistry       Date:  2000-07-18       Impact factor: 3.162

Review 3.  Molecular virology of the hepatitis C virus.

Authors:  R De Francesco
Journal:  J Hepatol       Date:  1999       Impact factor: 25.083

4.  Crystal structure of the RNA-dependent RNA polymerase of hepatitis C virus.

Authors:  H Ago; T Adachi; A Yoshida; M Yamamoto; N Habuka; K Yatsunami; M Miyano
Journal:  Structure       Date:  1999-11-15       Impact factor: 5.006

5.  Highly specific recognition of primer RNA structures for 2'-OH priming reaction by bacterial reverse transcriptases.

Authors:  S Inouye; M Y Hsu; A Xu; M Inouye
Journal:  J Biol Chem       Date:  1999-10-29       Impact factor: 5.157

6.  HIV-1 reverse transcriptase-pseudoknot RNA aptamer interaction has a binding affinity in the low picomolar range coupled with high specificity.

Authors:  O Kensch; B A Connolly; H J Steinhoff; A McGregor; R S Goody; T Restle
Journal:  J Biol Chem       Date:  2000-06-16       Impact factor: 5.157

7.  De novo RNA synthesis catalyzed by HCV RNA-dependent RNA polymerase.

Authors:  X L Sun; R B Johnson; M A Hockman; Q M Wang
Journal:  Biochem Biophys Res Commun       Date:  2000-02-24       Impact factor: 3.575

8.  De novo initiation of RNA synthesis by the RNA-dependent RNA polymerase (NS5B) of hepatitis C virus.

Authors:  G Luo; R K Hamatake; D M Mathis; J Racela; K L Rigat; J Lemm; R J Colonno
Journal:  J Virol       Date:  2000-01       Impact factor: 5.103

9.  De novo initiation of RNA synthesis by hepatitis C virus nonstructural protein 5B polymerase.

Authors:  W Zhong; A S Uss; E Ferrari; J Y Lau; Z Hong
Journal:  J Virol       Date:  2000-02       Impact factor: 5.103

10.  Template/primer requirements and single nucleotide incorporation by hepatitis C virus nonstructural protein 5B polymerase.

Authors:  W Zhong; E Ferrari; C A Lesburg; D Maag; S K Ghosh; C E Cameron; J Y Lau; Z Hong
Journal:  J Virol       Date:  2000-10       Impact factor: 5.103

View more
  31 in total

1.  High-affinity aptamers to subtype 3a hepatitis C virus polymerase display genotypic specificity.

Authors:  Louisa A Jones; Leighton E Clancy; William D Rawlinson; Peter A White
Journal:  Antimicrob Agents Chemother       Date:  2006-09       Impact factor: 5.191

2.  Design of peptide affinity ligands for S-protein: a comparison of combinatorial and de novo design strategies.

Authors:  Divya Chandra; Christopher J Morrison; James Woo; Steven Cramer; Pankaj Karande
Journal:  Mol Divers       Date:  2013-03-27       Impact factor: 2.943

3.  Selection and characterization of RNA aptamers to the RNA-dependent RNA polymerase from foot-and-mouth disease virus.

Authors:  Mark Ellingham; David H J Bunka; David J Rowlands; Nicola J Stonehouse
Journal:  RNA       Date:  2006-10-03       Impact factor: 4.942

4.  Integration of binding peptide selection and multifunctional particles as tool-box for capture of soluble proteins in serum.

Authors:  Angela Maria Cusano; Filippo Causa; Raffaella Della Moglie; Nunzia Falco; Pasqualina Liana Scognamiglio; Anna Aliberti; Raffaele Vecchione; Edmondo Battista; Daniela Marasco; Marika Savarese; Umberto Raucci; Nadia Rega; Paolo Antonio Netti
Journal:  J R Soc Interface       Date:  2014-10-06       Impact factor: 4.118

5.  Aptamers that preferentially bind type IVB pili and inhibit human monocytic-cell invasion by Salmonella enterica serovar typhi.

Authors:  Qin Pan; Xiao-Lian Zhang; Hong-Yan Wu; Pan-Wen He; Fubin Wang; Ming-Sheng Zhang; Jian-Ming Hu; Bing Xia; Jianguo Wu
Journal:  Antimicrob Agents Chemother       Date:  2005-10       Impact factor: 5.191

6.  Isolation of specific and high-affinity RNA aptamers against NS3 helicase domain of hepatitis C virus.

Authors:  Byounghoon Hwang; Jung Sun Cho; Hyeon Ju Yeo; Jung-Hye Kim; Kyung Min Chung; Kyungsook Han; Sung Key Jang; Seong-Wook Lee
Journal:  RNA       Date:  2004-07-09       Impact factor: 4.942

7.  CS-SELEX generates high-affinity ssDNA aptamers as molecular probes for hepatitis C virus envelope glycoprotein E2.

Authors:  Fang Chen; Yilan Hu; Dongqing Li; Haidan Chen; Xiao-Lian Zhang
Journal:  PLoS One       Date:  2009-12-03       Impact factor: 3.240

Review 8.  Modelling amorphous computations with transcription networks.

Authors:  Zack Booth Simpson; Timothy L Tsai; Nam Nguyen; Xi Chen; Andrew D Ellington
Journal:  J R Soc Interface       Date:  2009-05-27       Impact factor: 4.118

9.  Inhibition of hepatitis C virus (HCV) RNA polymerase by DNA aptamers: mechanism of inhibition of in vitro RNA synthesis and effect on HCV-infected cells.

Authors:  Pantxika Bellecave; Christian Cazenave; Julie Rumi; Cathy Staedel; Ophélie Cosnefroy; Marie-Line Andreola; Michel Ventura; Laura Tarrago-Litvak; Thérèse Astier-Gin
Journal:  Antimicrob Agents Chemother       Date:  2008-03-17       Impact factor: 5.191

10.  Mechanism of action and antiviral activity of benzimidazole-based allosteric inhibitors of the hepatitis C virus RNA-dependent RNA polymerase.

Authors:  Licia Tomei; Sergio Altamura; Linda Bartholomew; Antonino Biroccio; Alessandra Ceccacci; Laura Pacini; Frank Narjes; Nadia Gennari; Monica Bisbocci; Ilario Incitti; Laura Orsatti; Steven Harper; Ian Stansfield; Michael Rowley; Raffaele De Francesco; Giovanni Migliaccio
Journal:  J Virol       Date:  2003-12       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.